✦ LIBER ✦

Safety and Tolerability of PCK3145, a Synthetic Peptide Derived from Prostate Secretory Protein 94 (PSP94) in Metastatic Hormone-Refractory Prostate Cancer

✍ Scribed by Hawkins, Robert E.; Daigneault, Luc; Cowan, Richard; Griffiths, Richard; Panchal, Chandra; Armstrong, Anne; Fenemore, Jackie; Irvine, Alan; Sereda, Kasia; Dulude, Hélène

Book ID: 119935371
Publisher: CIG Media Group, LP.
Year: 2005
Tongue: English
Weight: 516 KB
Volume: 4
Category: Article
ISSN: 1540-0352
DOI: 10.3816/cgc.2005.n.016

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A prostate secretory protein94-derived s

A prostate secretory protein94-derived synthetic peptide PCK3145 inhibits VEGF signalling in endothelial cells: Implication in tumor angiogenesis

✍ Sylvie Lamy; Marcia T. Ruiz; Jan Wisniewski; Seema Garde; Shafaat A. Rabbani; Ch 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 378 KB

## Abstract We have previously observed that the synthetic peptide corresponding to amino acids 31–45 (PCK3145) of PSP94 can reduce prostate tumor growth __in vivo__. Moreover, a recently concluded phase IIa clinical trial with patients with hormone refractory prostate cancer indicated that PCK3145

A parathyroid-hormone-related-protein (P

A parathyroid-hormone-related-protein (PTH-rP)-specific cytotoxic T cell response induced by in vitro stimulation of tumour-infiltrating lymphocytes derived from prostate cancer metastases, with epitope peptide-loaded autologous dendritic cells and low-dose IL-2

✍ Correale, P. 📂 Article 📅 2001 🏛 Nature Publishing Group 🌐 English ⚖ 126 KB